Differences in Incremental Cost-Effectiveness Ratios for Common Versus Rare Conditions: A Case from Oncology
Crossref DOI link: https://doi.org/10.1007/s41669-017-0022-7
Published Online: 2017-04-25
Published Print: 2017-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jayasundara, Kavisha http://orcid.org/0000-0003-3548-9726
Krahn, Murray
Mamdani, Muhammad
Hoch, Jeffrey S.
Grootendorst, Paul
Funding for this research was provided by:
Canadian Institutes for Health Research (CIHR)
License valid from 2017-04-25